Dr. Ali is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Division of Leukemia
1500 East Duarte Road
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-389-3058- Is this information wrong?
Education & Training
City of Hope National Medical CenterFellowship, Hematopoietic Cell Transplantation, 2012 - 2013
University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
Loma Linda University Health Education ConsortiumResidency, Internal Medicine, 2004 - 2006
MedStar Health/Harbor HospitalInternship, Internal Medicine, 2003 - 2004
Rawalpindi Medical CollegeClass of 2001
Certifications & Licensure
CA State Medical License 2005 - 2025
TX State Medical License 2009 - 2024- American Board of Internal Medicine Hematology
Clinical Trials
- Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis Start of enrollment: 2016 Nov 13
- Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation Start of enrollment: 2020 Nov 11
Publications & Presentations
PubMed
- Mutations in Patients with Myeloid Neoplasms: A Cancer Center Multigene Next-Generation Sequencing Analysis Experience.Caitlin Caporale, Lisa Chang, Barbara K Fortini, Diana Bell, Milhan Telatar, Fei Fei, Haris Ali, Anthony Stein, Guido Marcucci, Michelle Afkhami> ;International Journal of Molecular Sciences. 2024 May 9
- Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancer.Al Malki, M. M., Jianying Zhang, Jose Tinajero, Hoda Pourhassan, Vinod Pullarkat, Vaibhav Agrawal, Paul Koller, Ahmed Aribi, Amandeep Salhotra, Karamjeet Sandhu, Haris...> ;British Journal of Haematology. 2024 Mar 31
- 1 citationsPhase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results.Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Aaron T Gerds, Gabriela Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati G...> ;Blood Advances. 2024 Mar 26
- Join now to see all
Abstracts/Posters
- Results from a Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate, or High Risk, Relapsed/Refractory MyelofibrosisHaris Ali, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Optimization of Tacrolimus Serum Levels When Combined with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Hematopoietic Cell Transplan...Haris Ali, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Peri-Transplant Administration of Ruxolitinib Is Safe and Feasible in Patients with Myelofibrosis: Primary Results of a Pilot Open-Label Study of Ruxolitinib Administr...Haris Ali, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate or High Risk Relapsed/Refractory Myelofibrosis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- MIPSS70+ V2.0 and Revised Cytogenetics Changes Predict Outcomes of Allogeneic Transplantation with Fludarabine and Melphalan Conditioning in Patients with Myelofibrosis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Clinical Outcomes of MDS Patients Who Were Allogeneic Hematopoietic Stem Cell Transplant Candidates but Did Not Proceed with Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
City of Hope Scientists Present Potential New Treatments for Chronic Lymphocytic Leukemia, Myelofibrosis and Other Diseases at American Association of Cancer Research (AACR) Annual MeetingApril 17th, 2023- Adding Itacitinib to Conventional GVHD ProphylaxisDecember 9th, 2022
City of Hope Physicians Report on New CAR-T Cell Therapy for Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm at American Society of Hematology Annual MeetingDecember 11th, 2017- Join now to see all
Professional Memberships
- Member
- American Society for Blood and Marrow TransplantationMember
Hospital Affiliations
City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
